1. Tanaka H, Sakurai Y, Suzuki M, Masunaga S, Kinashi Y, Kashino G, et al.
Characteristics comparison between a cyclotron-based neutron
source and KUR-HWNIF for boron neutron capture therapy. Nucl
23. Instruments Methods Phys Res Sect B Beam Interact Mater Atoms.
2009;267(11):1970–7. https://doi.org/10.1016/j.nimb.2009.03.095.
Tanaka H, Sakurai Y, Suzuki M, Masunaga S, Mitsumoto T, Fujita K,
et al. Experimental verification of beam characteristics for cyclotron-based epithermal neutron source (C-BENS). Appl Radiat Isot.
2011;69(12):1642–5. https://doi.org/10.1016/j.apradiso.2011.03.020.
Miyatake SI, Wanibuchi M, Hu N, Ono K. Boron neutron capture therapy
for malignant brain tumors. J Neurooncol. 2020;149(1):1–11. https://
doi.org/10.1007/s11060-020-03586-6.
Kumada H, Takada K. Treatment planning system and patient
positioning for boron neutron capture therapy. Ther Radiol Oncol.
2018;2:50–50.
Nigg DW, Wheeler FJ, Wessol DE, Capala J, Chadha M. Computational
dosimetry and treatment planning for boron neutron capture therapy. J
Neurooncol. 1997;33(1–2):93–104.
Zamenhof RG, Redmond E, Solares G, Katz D, Riley K, Kiger S, et al. Monte
Carlo-based treatment planning for boron neutron capture therapy using
custom designed models automatically generated from CT data. Int J
Radiat Oncol Biol Phys. 1996;35(2):383–97.
Wojnecki C, Green S. A preliminary comparative study of two treatment
planning systems developed for boron neutron capture therapy: MacNCTPlan and SERA. Med Phys. 2002;29(8):1710–5.
Goorley JT, Kiger WS, Zamenhof RG. Reference dosimetry calculations
for Neutron Capture Therapy with comparison of analytical and voxel
models. Med Phys. 2002;29(2):145–56.
Sato T, Iwamoto Y, Hashimoto S, Ogawa T, Furuta T, Abe S, et al. Features
of particle and heavy ion transport code system (PHITS) version 3.02. J
Nucl Sci Technol. 2018;55(6):684–90. https://doi.org/10.1080/00223131.
2017.1419890.
Kato I, Fujita Y, Maruhashi A, Kumada H, Ohmae M, Kirihata M, et al. Effectiveness of boron neutron capture therapy for recurrent head and neck
malignancies. Appl Radiat Isot. 2009;67(7–8):S37-42.
Miyatake SI, Kawabata S, Yokoyama K, Kuroiwa T, Michiue H, Sakurai Y,
et al. Survival benefit of Boron neutron capture therapy for recurrent
malignant gliomas. J Neurooncol. 2009;91(2):199–206.
Suzuki M, Sakurai Y, Hagiwara S, Masunaga S, Kinashi Y, Nagata K, et al.
First attempt of boron neutron capture therapy (BNCT) for hepatocellular
carcinoma. Jpn J Clin Oncol. 2007;37(5):376–81.
Suzuki M, Endo K, Satoh H, Sakurai Y, Kumada H, Kimura H, et al. A novel
concept of treatment of diffuse or multiple pleural tumors by boron
neutron capture therapy (BNCT). Radiother Oncol. 2008;88(2):192–5.
Kawabata S, Suzuki M, Hirose K, Tanaka H, Kato T, Goto H, et al. Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter
phase II study. Neuro-Oncol Adv. 2021;3(1):1–9.
Sakamoto Y, Iwai S, Sato O, Tanaka S, Tsuda S, Yamaguchi Y, et al. Dose
conversion coefficients for high-energy photons, electrons, neutrons and
protons. JAERI-1345. 2003;
Shibata K, Iwamoto O, Nakagawa T, Iwamoto N, Ichihara A, Kunieda S,
et al. JENDL-4.0: a new library for nuclear science and engineering. J Nucl
Sci Technol. 2011;48(1):1–30.
Nigg D, Wemple C, Wessol D, Wheeler F, Albright C, Cohen M, et al.
SERA—an advanced treatment planning system for neutron therapy and
BNCT. Trans Am Nucl Soc. 1999;80:223–32.
Wheeler F, Wessol D, Wemple C, Albright C, Cohen M, Frandsen M, et al.
SERA—an advanced treatment planning system for neutron therapy.
Ineel/Con-99. 1999;00523.
Blue TE, Gupta N, Woollard JE. A calculation of the energy dependence of
the RBE of neutrons. Phys Med Biol. 1993;38(12):1693–712.
Yanch JC, Zhou XL, Brownell GL. A Monte Carlo investigation of the dosimetric properties of monoenergetic neutron beams for neutron capture
therapy. Radiat Res. 1991;126(1):1–20.
International Atomic Energy Agency. Current Status of Neutron Capture
Therapy. Vienna: IAEA-TECDOC-1223; 2001. (TECDOC Series).
Sakurai Y, Kobayashi T. Characteristics of the KUR heavy water neutron
irradiation facility as a neutron irradiation field with variable energy spectra. Nucl Instruments Methods Phys Res Sect A Accel Spectrom Detect
Assoc Equip. 2000;453(3):569–96.
Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol
S, et al. 3D Slicer as an image computing platform for the Quantitative
Imaging Network. Magn Reson Imaging. 2012;30(9):1323–41.
A Self-archived copy in
Kyoto University Research Information Repository
https://repository.kulib.kyoto-u.ac.jp
Hu et al. Radiation Oncology
(2021) 16:243
Page 13 of 13
24. Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative
evaluation of dose distributions. Med Phys. 1998;25(5):656–61. https://
doi.org/10.1118/1.598248.
25. Alexander K, Jechel C, Pinter C, Salomons G, Lasso A, Fichtinger G, et al.
SU-E-T-231: cross-validation of 3D gamma comparison tools. Med Phys.
2015;42(6Part15):3385–3385. https://doi.org/10.1118/1.4924592.
26. International Atomic Energy Agency. Commissioning and Quality
Assurance of Computerized Planning Systems for Radiation Treatment
of Cancer. Vienna: International Atomic Energy Agency; 2004. (Technical
Reports Series).
27. Daquino GG, Voorbraak WP. A review of the recommendations for the
physical dosimetry of boron neutron capture therapy (BNCT). Daquino
GG, Voorbraak WP, editors. Luxembourg: EUR; 2008.
28. Kumada H, Takada K, Aihara T, Matsumura A, Sakurai H, Sakae T.
Verification for dose estimation performance of a Monte-Carlo based
treatment planning system in University of Tsukuba. Appl Radiat Isot.
2019;2020(166):109222. https://doi.org/10.1016/j.apradiso.2020.109222.
29. Pu N, Nishitani T, Isobe M, Ogawa K, Kawase H, Tanaka T, et al. In situ
calibration of neutron activation system on the large helical device. Rev
Sci Instrum. 2017;88(11):113302. https://doi.org/10.1063/1.5009475.
30. Kobayashi M, Nishitani T, Kato A, Saze T, Tanaka T, Yoshihashi S, et al. Evaluation of imaging plate measurement for activated indium as fast-neutron
detector in large radiation field. Prog Nucl Sci Technol. 2019;6:58–62.
31. Miften M, Olch A, Mihailidis D, Moran J, Pawlicki T, Molineu A, et al. Tolerance limits and methodologies for IMRT measurement-based verification QA: recommendations of AAPM Task Group No. 218. Med Phys.
2018;45(4):e53-83.
32. Nigg DW. Computational dosimetry and treatment planning considerations for neutron capture therapy. 2003;75–86.
33. Stern RL, Heaton R, Fraser MW, Murty Goddu S, Kirby TH, Lam KL, et al.
Verification of monitor unit calculations for non-IMRT clinical radiotherapy: report of AAPM Task Group 114. Med Phys. 2011;38(1):504–30.
34. Coderre JA, Makar MS, Micca PL, Nawrocky MM, Liu HB, Joel DD, et al.
Derivations of relative biological effectiveness for the high-let radiations
produced during boron neutron capture irradiations of the 9l rat gliosarcoma in vitro and in vivo. Int J Radiat Oncol Biol Phys. 1993;27(5):1121–9.
35. Coderre JA, Chanana AD, Joel DD, Elowitz EH, Micca PL, Nawrocky MM,
et al. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.
Radiat Res. 1998;149(2):163–70.
36. Fukuda H, Hiratsuka J, Kobayashi T, Sakurai Y, Yoshino K, Karashima H,
et al. Boron neutron capture therapy (BNCT) for malignant melanoma
with special reference to absorbed doses to the normal skin and tumor.
Australas Phys Eng Sci Med. 2003;26(3):97–103.
37. Coderre JA, Morris GM, Micca PL, Fisher CD, Ross GA. Comparative assessment of single-dose and fractionated boron neutron capture therapy.
Radiat Res. 1995;144(3):310–7.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Ready to submit your research ? Choose BMC and benefit from:
• fast, convenient online submission
• thorough peer review by experienced researchers in your field
• rapid publication on acceptance
• support for research data, including large and complex data types
• gold Open Access which fosters wider collaboration and increased citations
• maximum visibility for your research: over 100M website views per year
At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
...
論文の公開元へ
